Role of Anti-Inflammatory Agents in Patients With Schizophrenia

NCT00929955 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder
Psychosis Not Otherwise Specified
Schizophreniform Disorder

Interventions

DRUG: Ondansetron
DRUG: Simvastatin
DRUG: Placebo

Sponsor

Pakistan Institute of Living and Learning

Collaborators

[object Object]
[object Object]